139 related articles for article (PubMed ID: 30499807)
1. Reintervention After Antireflux Surgery for Gastroesophageal Reflux Disease in England.
Markar SR; Arhi C; Wiggins T; Vidal-Diez A; Karthikesalingam A; Darzi A; Lagergren J; Hanna GB
Ann Surg; 2020 Apr; 271(4):709-715. PubMed ID: 30499807
[TBL] [Abstract][Full Text] [Related]
2. Association Between Laparoscopic Antireflux Surgery and Recurrence of Gastroesophageal Reflux.
Maret-Ouda J; Wahlin K; El-Serag HB; Lagergren J
JAMA; 2017 Sep; 318(10):939-946. PubMed ID: 28898377
[TBL] [Abstract][Full Text] [Related]
3. The Influence of Antireflux Surgery on Esophageal Cancer Risk in England: National Population-based Cohort Study.
Markar SR; Arhi C; Leusink A; Vidal-Diez A; Karthikesalingam A; Darzi A; Lagergren J; Hanna GB
Ann Surg; 2018 Nov; 268(5):861-867. PubMed ID: 30048317
[TBL] [Abstract][Full Text] [Related]
4. Esophageal Adenocarcinoma After Antireflux Surgery in a Cohort Study From the 5 Nordic Countries.
Maret-Ouda J; Santoni G; Wahlin K; Artama M; Brusselaers N; Färkkilä M; Lynge E; Mattsson F; Pukkala E; Romundstad P; Tryggvadóttir L; von Euler-Chelpin M; Lagergren J
Ann Surg; 2021 Dec; 274(6):e535-e540. PubMed ID: 31800492
[TBL] [Abstract][Full Text] [Related]
5. Hospital Volume of Antireflux Surgery in Relation to Endoscopic and Surgical Re-interventions.
Markar S; Santoni G; Maret-Ouda J; Artama M; Färkkilä M; Lynge E; Pukkala E; Ness-Jensen E; von Euler-Chelpin M; Lagergren J
Ann Surg; 2021 Dec; 274(6):e1138-e1143. PubMed ID: 31913870
[TBL] [Abstract][Full Text] [Related]
6. Measuring the effectiveness of laparoscopic antireflux surgery: long-term results.
Gee DW; Andreoli MT; Rattner DW
Arch Surg; 2008 May; 143(5):482-7. PubMed ID: 18490558
[TBL] [Abstract][Full Text] [Related]
7. Risk of Esophageal Adenocarcinoma After Antireflux Surgery in Patients With Gastroesophageal Reflux Disease in the Nordic Countries.
Maret-Ouda J; Wahlin K; Artama M; Brusselaers N; Färkkilä M; Lynge E; Mattsson F; Pukkala E; Romundstad P; Tryggvadóttir L; von Euler-Chelpin M; Lagergren J
JAMA Oncol; 2018 Nov; 4(11):1576-1582. PubMed ID: 30422249
[TBL] [Abstract][Full Text] [Related]
8. Surgical reintervention after antireflux surgery for gastroesophageal reflux disease: a prospective cohort study in 130 patients.
Furnée EJ; Draaisma WA; Broeders IA; Smout AJ; Gooszen HG
Arch Surg; 2008 Mar; 143(3):267-74; discussion 274. PubMed ID: 18347274
[TBL] [Abstract][Full Text] [Related]
9. Mortality, Reoperation, and Hospital Stay Within 90 Days of Primary and Secondary Antireflux Surgery in a Population-Based Multinational Study.
Yanes M; Santoni G; Maret-Ouda J; Markar S; Ness-Jensen E; Kauppila J; Färkkilä M; Lynge E; Pukkala E; Tryggvadóttir L; von Euler-Chelpin M; Lagergren J
Gastroenterology; 2021 Jun; 160(7):2283-2290. PubMed ID: 33587926
[TBL] [Abstract][Full Text] [Related]
10. Antireflux Surgery and Risk of Esophageal Adenocarcinoma: A Systematic Review and Meta-analysis.
Maret-Ouda J; Konings P; Lagergren J; Brusselaers N
Ann Surg; 2016 Feb; 263(2):251-7. PubMed ID: 26501714
[TBL] [Abstract][Full Text] [Related]
11. Use of antireflux medication after antireflux surgery.
Wijnhoven BP; Lally CJ; Kelly JJ; Myers JC; Watson DI
J Gastrointest Surg; 2008 Mar; 12(3):510-7. PubMed ID: 18071830
[TBL] [Abstract][Full Text] [Related]
12. Continued (5-year) followup of a randomized clinical study comparing antireflux surgery and omeprazole in gastroesophageal reflux disease.
Lundell L; Miettinen P; Myrvold HE; Pedersen SA; Liedman B; Hatlebakk JG; Julkonen R; Levander K; Carlsson J; Lamm M; Wiklund I
J Am Coll Surg; 2001 Feb; 192(2):172-9; discussion 179-81. PubMed ID: 11220717
[TBL] [Abstract][Full Text] [Related]
13. Laryngeal and Pharyngeal Squamous Cell Carcinoma After Antireflux Surgery in the 5 Nordic Countries.
Yanes M; Santoni G; Maret-Ouda J; Ness-Jensen E; Färkkilä M; Lynge E; Pukkala E; Romundstad P; Tryggvadóttir L; Euler-Chelpin MV; Lagergren J
Ann Surg; 2022 Aug; 276(2):e79-e85. PubMed ID: 33074906
[TBL] [Abstract][Full Text] [Related]
14. Proton Pump Inhibitor Use After Hiatal Hernia Repair: Inhibitor of Recurrent Symptoms and Potential Revisional Surgery.
Oppenheimer EE; Schmit B; Sarosi GA; Thomas RM
J Surg Res; 2020 Dec; 256():570-576. PubMed ID: 32805579
[TBL] [Abstract][Full Text] [Related]
15. Proton Pump Inhibitor-Refractory Gastroesophageal Reflux Disease.
Yadlapati R; DeLay K
Med Clin North Am; 2019 Jan; 103(1):15-27. PubMed ID: 30466671
[TBL] [Abstract][Full Text] [Related]
16. Therapy with proton-pump inhibitors for gastroesophageal reflux disease does not reduce the risk for severe exacerbations in COPD.
Baumeler L; Papakonstantinou E; Milenkovic B; Lacoma A; Louis R; Aerts JG; Welte T; Kostikas K; Blasi F; Boersma W; Torres A; Rohde GG; Boeck L; Rakic J; Scherr A; Tamm M; Stolz D
Respirology; 2016 Jul; 21(5):883-90. PubMed ID: 26970108
[TBL] [Abstract][Full Text] [Related]
17. Antireflux surgery in the proton pump inhibitor era.
Bulsiewicz WJ; Madanick RD
Cleve Clin J Med; 2012 Apr; 79(4):273-81. PubMed ID: 22473727
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial.
Spechler SJ; Lee E; Ahnen D; Goyal RK; Hirano I; Ramirez F; Raufman JP; Sampliner R; Schnell T; Sontag S; Vlahcevic ZR; Young R; Williford W
JAMA; 2001 May; 285(18):2331-8. PubMed ID: 11343480
[TBL] [Abstract][Full Text] [Related]
19. Laparoscopic antireflux surgery (LARS) is highly effective in the treatment of select patients with chronic cough.
Park A; Weltz AS; Sanford Z; Addo A; Zahiri HR
Surgery; 2019 Jul; 166(1):34-40. PubMed ID: 30955850
[TBL] [Abstract][Full Text] [Related]
20. Antireflux surgery and risk of lung cancer by histological type in a multinational cohort study.
Yanes M; Santoni G; Maret-Ouda J; Ness-Jensen E; Färkkilä M; Lynge E; Nwaru B; Pukkala E; Romundstad P; Tryggvadóttir L; von Euler-Chelpin M; Lagergren J
Eur J Cancer; 2020 Oct; 138():80-88. PubMed ID: 32877797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
